Tetra Pak announces first collaboration with food processing technology incubator

Intertape Polymer Group Inc. announced that it has entered into a definitive agreement to be acquired by an affiliate of Clearlake Capital Group, L.P. (together with certain of its affiliates, “Clearlake”). Under the terms of the agreement, Clearlake will acquire the outstanding shares of IPG for CDN$40.50 per share in an all-cash transaction valued at approximately US$2.6 billion, including net debt. This represents a premium of approximately 82% to the closing price of IPG common shares on the Toronto Stock Exchange on March 7, 2022 and approximately 66% to the volume weighted average trading price of IPG common shares on the Toronto Stock Exchange for the preceding 30 trading days. Upon completion of the transaction, IPG will become a privately held company. “We believe this transaction is a great next step in the evolution of our business as Clearlake has strong industry knowledge in the protective packaging and e-commerce ecosystems. Clearlake provides us the operational and financial resources to accelerate our acquisition strategy, as well as organic growth opportunities such as investing in product innovation, sustainability, and market expansion,” said Greg Yull, President and Chief Executive Officer of IPG. “We have built a scaled business serving a diverse set of growing end markets, and have seen particularly strong growth in our large e-commerce segment. Clearlake’s investment reflects its confidence in our people, processes, and strategy, and this transaction will advance our vision of becoming a global leader in packaging and protective solutions. We believe this all-cash transaction represents an attractive return and provides certainty for our shareholder base.”

Ensuring that vaccine vials and their potentially life-changing contents remain safe, sterile and identifiable throughout their tightly controlled supply chain is no easy task, and taking risks is not an option. With the new extended 360 Service offering, Metsä Board, part of Metsä Group, is testing the paperboards and simulating packaging designs used by pharma manufacturers to package and protect vaccine doses, providing absolute confidence that the materials are up to the task. COVID-19 and other vaccines are typically stored and transported in extremely cold conditions, which can be as low as -70 degrees Celsius, before being thawed out ready for administration. The secondary paperboard packaging must be able to withstand these temperature extremes and protect the vials throughout the entire process. When a converter is producing packages for cold-chain transportation they have to be 100% certain that the materials they are using are appropriate. This is where Metsä Board’s in-depth testing and simulation capabilities are extremely valuable for the pharma industry.

Ahlstrom expands its offering for the medical industry by introducing Reliance® Fusion, a next-generation simultaneous sterilization wrap that helps increase efficiency in the sterilization of surgical equipment trays at hospitals. Sterilization wraps are extensively used in healthcare facilities worldwide to help maintain the sterility of surgical instruments. Ahlstrom single-use sterilization wraps help to prevent microorganisms (bacteria, viruses, spores) from easily gaining access to the tray contents, allow sterilization, provide physical protection, and maintain sterility of surgical instruments up to the point of use. They thus play a crucial role in infection prevention and patients’ safety. The sterilization process is often time-consuming, requires the use of expensive processing aids such as tray liners, and involves longer drying cycles and stocking multiple weights of sterilization wrap to ensure all moisture has been eliminated.